Literature DB >> 21814215

Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans.

Keith M Diaz1, Praveen Veerabhadrappa, Mohammed A Kashem, Deborah L Feairheller, Kathleen M Sturgeon, Sheara T Williamson, Deborah L Crabbe, Michael D Brown.   

Abstract

Visit-to-visit clinic blood pressure variability (BPV) and 24-h BPV have both been identified as independent risk factors for cardiovascular (CV) morbidity and mortality; however, the mechanisms contributing to the increased CV risk as yet are unclear. The purpose of this study was to assess the relationship between BPV and endothelial function in a cohort of putatively healthy African Americans. A total of 36 African Americans who were sedentary, non-diabetic, non-smoking, free of CV and renal disease and not on antihypertensive medication followed an American Heart Association low fat, low salt diet for 6 weeks. Upon completion of the 6-week dietary stabilization period, participants underwent 24-h ambulatory BP monitoring and had their office blood pressure (BP) measured on 3 separate days. Right brachial artery diameter was assessed at rest, during reactive hyperemia (flow-mediated vasodilation: FMD), and after nitroglycerin administration (nitroglycerin-mediated vasodilation: NMD). Participants classified as having decreased endothelial function according to either %FMD or the FMD/NMD ratio had significantly higher 24-h BPV and a trend for higher visit-to-visit BPV when compared with participants with normal endothelial function. Continuous variable analyses revealed a significant positive association between NMD and 24-h diastolic BPV (DBPV). Visit-to-visit systolic BPV (SBPV), 24-h SBPV and 24-h DBPV were all negatively associated with the FMD/NMD ratio. All relationships remained significant after adjustment for age, body mass index and mean BP levels. These results may suggest that BPV is increased in African Americans with decreased endothelial function and is associated with the vascular smooth muscle response to nitric oxide.

Entities:  

Mesh:

Year:  2011        PMID: 21814215      PMCID: PMC3629695          DOI: 10.1038/hr.2011.135

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  36 in total

1.  Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults.

Authors:  Jerome L Abramson; Cheryl Lewis; Nancy V Murrah; Grant T Anderson; Viola Vaccarino
Journal:  Am J Cardiol       Date:  2006-07-07       Impact factor: 2.778

2.  Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study.

Authors:  Giuseppe Mancia; Michele Bombelli; Rita Facchetti; Fabiana Madotto; Giovanni Corrao; Fosca Quarti Trevano; Guido Grassi; Roberto Sega
Journal:  Hypertension       Date:  2007-04-23       Impact factor: 10.190

3.  Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study.

Authors:  Masahiro Kikuya; Takayoshi Ohkubo; Kei Asayama; Hirohito Metoki; Taku Obara; Shin Saito; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai
Journal:  Hypertension       Date:  2004-12-13       Impact factor: 10.190

4.  Inflammation is involved in the organ damage induced by sinoaortic denervation in rats.

Authors:  Chuan Zhang; Hong Chen; He-Hui Xie; He Shu; Wen-Jun Yuan; Ding-Feng Su
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke.

Authors:  S C Howard; P M Rothwell
Journal:  Cerebrovasc Dis       Date:  2009-07-24       Impact factor: 2.762

7.  Association between blood pressure variability and inflammatory marker in hypertensive patients.

Authors:  Kwang-Il Kim; Jae-Hee Lee; Hyuk-Jae Chang; Young-Seok Cho; Tae-Jin Youn; Woo-Young Chung; In-Ho Chae; Dong-Ju Choi; Kyoung Un Park; Cheol-Ho Kim
Journal:  Circ J       Date:  2008-02       Impact factor: 2.993

8.  Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension.

Authors:  Alfonso Tatasciore; Marco Zimarino; Giulia Renda; Maria Zurro; Manola Soccio; Concetta Prontera; Michele Emdin; Mariarosaria Flacco; Giuseppe Schillaci; Raffaele DE Caterina
Journal:  Hypertens Res       Date:  2008-12       Impact factor: 3.872

9.  Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria.

Authors:  L Sibal; A Aldibbiat; S C Agarwal; G Mitchell; C Oates; S Razvi; J U Weaver; J A Shaw; P D Home
Journal:  Diabetologia       Date:  2009-05-30       Impact factor: 10.122

10.  Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes.

Authors:  Esko J Wiltshire; Roger Gent; Craig Hirte; Alexia Pena; David W Thomas; Jennifer J Couper
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

View more
  52 in total

Review 1.  Is It Daily, Monthly, or Yearly Blood Pressure Variability that Enhances Cardiovascular Risk?

Authors:  Eamon Dolan; Eoin O'Brien
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

2.  Visit-to-Visit Blood Pressure Variability, Coronary Atheroma Progression, and Clinical Outcomes.

Authors:  Donald Clark; Stephen J Nicholls; Julie St John; Mohamed B Elshazly; Haitham M Ahmed; Haitham Khraishah; Steven E Nissen; Rishi Puri
Journal:  JAMA Cardiol       Date:  2019-05-01       Impact factor: 14.676

3.  Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.

Authors:  Jeff Whittle; Amy I Lynch; Rikki M Tanner; Lara M Simpson; Barry R Davis; Mahboob Rahman; Paul K Whelton; Suzanne Oparil; Paul Muntner
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 8.237

Review 4.  Blood pressure variability: assessment, predictive value, and potential as a therapeutic target.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 5.  Assessment and management of blood-pressure variability.

Authors:  Gianfranco Parati; Juan E Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

6.  Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study.

Authors:  Chenkai Wu; Michael G Shlipak; Robert S Stawski; Carmen A Peralta; Bruce M Psaty; Tamara B Harris; Suzanne Satterfield; Eric J Shiroma; Anne B Newman; Michelle C Odden
Journal:  Am J Hypertens       Date:  2016-09-06       Impact factor: 2.689

7.  Association of BP variability with mortality among African Americans with CKD.

Authors:  Ciaran J McMullan; George L Bakris; Robert A Phillips; John P Forman
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-14       Impact factor: 8.237

8.  Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Daichi Shimbo; Steven Shea; Robyn L McClelland; Anthony J Viera; Devin Mann; Jonathan Newman; Joao Lima; Joseph F Polak; Bruce M Psaty; Paul Muntner
Journal:  Am J Hypertens       Date:  2013-03-28       Impact factor: 2.689

Review 9.  Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

Authors:  Gianfranco Parati; Juan E Ochoa; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

10.  Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.

Authors:  Tara I Chang; Grace H Tabada; Jingrong Yang; Thida C Tan; Alan S Go
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.